Is Neurobo Pharmaceuticals Inc (NRBO) a Loser in the Healthcare Sector?

Neurobo Pharmaceuticals Inc (NRBO) is near the bottom in its sector according to InvestorsObserver. NRBO gets an overall rating of 12. That means it scores higher than 12% of stocks. Neurobo Pharmaceuticals Inc gets a 6 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

NRBO has an Overall Score of 12. Find out what this means to you and get the rest of the rankings on NRBO!

See Full NRBO Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 12 would rank higher than 12 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Neurobo Pharmaceuticals Inc Stock Today?

Neurobo Pharmaceuticals Inc (NRBO) stock has gained 8.92% while the S&P 500 has fallen -0.78% as of 10:45 AM on Friday, Dec 2. NRBO has gained $0.13 from the previous closing price of $1.43 on volume of 429,086 shares. Over the past year the S&P 500 is down -11.63% while NRBO has fallen -96.51%. NRBO lost -$15.64 per share the over the last 12 months. Click Here to get the full Stock Report for Neurobo Pharmaceuticals Inc stock.